Latest Breaking News On - Jon gingrich - Page 4 : comparemela.com

Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management

Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management Echosens, a high-technology company offering the FibroScan family of products, today announces the global launch of FibroScan-based Agile scores to easily detect advanced fibrosis and cirrhosis in non-alcoholic fatty liver disease (NAFLD) patients, reduce the number of false positive cases compared to liver stiffness measurement by vibration controlled transient elastography (LSM by VCTE) alone, accurately predict liver complications and, in coming years, identify patients eligible for pharmaceutical treatments. Learn more about myFibroScan here. Agile scores deliver a new level of value to the FibroScan solution by enhancing capabilities in the management of non-alcoholic fatty liver patients, improving early identification of those who are at risk and helping providers initiate the right intervention, says

Kostenloser wertpapierhandelJon gingrichDominique legrosBrittany tedescoInternational liver congressLiver congressFibroscan based agileEchosens north americaஆதிக்கம் லெக்ரோஸ்பிரிட்டானி தேதேஸ்கோசர்வதேச கல்லீரல் காங்கிரஸ்கல்லீரல் காங்கிரஸ்

Echosens Sponsors First Annual Liver Health Matters Month in June, Celebrates 20 Years of Battling Liver Disease Epidemic, Preventing Disease Progression

As part of its 20th anniversaryEchosens, a high-technology company offering the FibroScanfamily of products, is pleased to announce its sponsorship of the first annual Liver Health Matters Month, an

Kostenloser wertpapierhandelJon gingrichDominique legrosBrittany tedescoDownload echosen liver health matters toolkitLiver health matters monthEchosen liver health matters toolkitEchosens north americaHealth matters monthஆதிக்கம் லெக்ரோஸ்பிரிட்டானி தேதேஸ்கோ

Echosens richtet im Juni den ersten jährlichen Liver Health Matters Month aus und feiert 20 Jahre Bekämpfung der epidemischen Lebererkrankung und Verhinderung des Fortschreitens dieser Krankheit

Echosens richtet im Juni den ersten jährlichen Liver Health Matters Month aus und feiert 20 Jahre Bekämpfung der epidemischen Lebererkrankung und Verhinderung des Fortschreitens dieser Krankheit
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Jon gingrichSuccesses in combating the developmentLiver health mattersLiver health matters monthInformation campaignEchosens liver health mattersCpr communicationsJune theFda authorisedBlutfettwerten andGroup chiefNeed forEchosens north americaAbout echosensMillions of theOriginal text

Echosens sponsorise le premier événement annuel Liver Health Matters Month en juin, qui célèbre 20 années de lutte contre l épidémie de maladies du foie et de prévention de la progression des maladies

Echosens sponsorise le premier événement annuel Liver Health Matters Month en juin, qui célèbre 20 années de lutte contre l épidémie de maladies du foie et de prévention de la progression des maladies
itespresso.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itespresso.fr Daily Mail and Mail on Sunday newspapers.

Jon gingrichLiver which matters monthEvent which mattersLiver which mattersd echosensNorth americaD echosens pioneerவடக்கு அமெரிக்கா

Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease -

by Jon Gingrich, CEO, Echosens North America Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and provider organizations that include this approach to testing. At a time when America’s hospitals and physician groups face lost revenues due to the COVID-19 pandemic, there is a pressing need for reducing costs while maintaining high-quality patient care. Awareness is growing around the prevalence and costs associated with underdiagnosed liver disease, which is associated with over $100B in annual direct costs.

United statesJon gingrichAmerican hospital associationEchosens northPatient engagementஒன்றுபட்டது மாநிலங்களில்அமெரிக்கன் மருத்துவமனை சங்கம்நோயாளி நிச்சயதார்த்தம்